Abstract
Hypertensive disorders of pregnancy is one of the most common causes of high maternal mortality in India and globally as well. Hypertension in pregnancy is associated with many adverse effects for both mother and baby. Blood pressure reading ≥160/110 mmHg is often associated with increased risk of complications like placental abruption, pulmonary edema, hypertensive encephalopathy, intracranial hemorrhage, eclampsia and other end organ damage with poor perinatal outcome. The present study aimed to compare the two most commonly used drugs, oral nifedipine and IV labetalol in terms of their adverse effects, maternal and perinatal outcomes. Both intravenous labetalol and nifedipine have been compared directly with many other antihypertensive agents; however, literature on their direct comparison with each other for adverse effect is very limited.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Obstetrics and Gynecology Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
